AI assistant
Sending…
AYTU BIOPHARMA, INC — Director's Dealing 2016
Jul 18, 2016
35030_dirs_2016-07-18_f66348ff-bf8f-41f7-8a3a-dd3fbd7dff97.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AYTU BIOSCIENCE, INC (AYTU)
CIK: 0001385818
Period of Report: 2016-07-12
Reporting Person: Donofrio John Jr. (Director)
More from AYTU BIOPHARMA, INC
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Regulatory Filings
2026
Jan 20
Regulatory Filings
2025
Dec 10
Major Shareholding Notification
2025
Nov 14
Interim / Quarterly Report
2025
Nov 13
Regulatory Filings
2025
Nov 13
Major Shareholding Notification
2025
Nov 12